DURHAM, N.C.--(BUSINESS WIRE)--Bioventus, a leader in active orthopaedic healing, today announced that it has entered into an agreement with Galderma to acquire the International assets for DUROLANE®, a product that helps relieve the pain of osteoarthritis (OA) in a variety of joints.* Bioventus previously had exclusive global distribution rights and served as the distributor for DUROLANE in Europe, Canada and Australia.
Help employers find you! Check out all the jobs and post your resume.
